JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $120

Benzinga · 3d ago
JP Morgan analyst Robbie Marcus maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $117 to $120.